Company Data

Trevena Inc.

Advanced Market Data

Ticker

TRVN

Current Price

$0.275

Market Cap

$237.5K

Price Target

Refer to Report

Volume

168

52wk Range

$0.25 - $7.85

Advanced Market Data

Overview

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Other Considerations

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Nutriband Inc.

NTRB (NSC)

$6.435

$6.31(1.98%)

89.7M

20.5K

$2.97784 - $9.424

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Unicycive Therapeutics Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc.

UNCY (NSC)

$4.2

$4.25(-1.18%)

74.2M

408.1K

$2.833 - $11

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Cadrenal Therapeutics Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc.

CVKD (NSC)

$12.48

$12.45(0.24%)

25.5M

18.9K

$6.805 - $22.9011

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

LakeShore Biopharma Co. Ltd.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

LakeShore Biopharma Co. Ltd.

LakeShore Biopharma Co. Ltd.

LSB (NSC)

$0.829

$0.84(-0.84%)

34.2M

5.2K

$0.59 - $8.6

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

MAIA Biotechnology Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

MAIA Biotechnology Inc.

MAIA Biotechnology Inc.

MAIA (AMX)

$1.58

$1.53(3.27%)

52.1M

102.3K

$1.4 - $3.742

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Baudax Bio Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Baudax Bio Inc.

Baudax Bio Inc.

BXRX (Nasdaq)

1.2M

$0.0137 - $3.4699

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Eledon Pharmaceuticals

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Eledon Pharmaceuticals

Eledon Pharmaceuticals

ELDN (Nasdaq)

$2.6

$2.56(1.56%)

155.7M

716.5K

$2.375 - $5.54

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Tonix Pharmaceuticals Holding Corp.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.

TNXP (Nasdaq)

$37.98

$35.85(5.94%)

332.9M

1.7M

$6.76 - $130

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Ocugen, Inc.

OCGN (Nasdaq)

$1.01

295.2M

2.3M

$0.515 - $1.4

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

PDS Biotechnology Corporation

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

PDS Biotechnology Corporation

PDS Biotechnology Corporation

PDSB (Nasdaq)

$1.19

$1.15(3.48%)

55.5M

240.5K

$0.8505 - $4.29

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data